These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 10788680)
21. Serotonergic function in major depression and effect of sertraline and paroxetine treatment. Stain-Malmgren R; Khoury AE; Aberg-Wistedt A; Tham A Int Clin Psychopharmacol; 2001 Mar; 16(2):93-101. PubMed ID: 11236074 [TBL] [Abstract][Full Text] [Related]
22. High affinity [3H]imipramine and [3H]paroxetine binding sites in suicide brains. Rosel P; Arranz B; Vallejo J; Oros M; Menchón JM; Alvarez P; Navarro MA J Neural Transm (Vienna); 1997; 104(8-9):921-9. PubMed ID: 9451724 [TBL] [Abstract][Full Text] [Related]
23. Influence of menstrual cycle on platelet serotonin uptake site and serotonin2A receptor binding. Wihlbäck AC; Sundström Poromaa I; Bixo M; Allard P; Mjörndal T; Spigset O Psychoneuroendocrinology; 2004 Jul; 29(6):757-66. PubMed ID: 15110925 [TBL] [Abstract][Full Text] [Related]
25. Serotonergic activity measured by platelet [3H]paroxetine binding in patients with eating disorders. Ramacciotti CE; Coli E; Paoli R; Marazziti D; Dell'Osso L Psychiatry Res; 2003 May; 118(1):33-8. PubMed ID: 12759159 [TBL] [Abstract][Full Text] [Related]
26. Decreased platelet serotonin transporter sites and increased platelet inositol triphosphate levels in patients with unipolar depression: effects of clomipramine and fluoxetine. Alvarez JC; Gluck N; Arnulf I; Quintin P; Leboyer M; Pecquery R; Launay JM; Perez-Diaz F; Spreux-Varoquaux O Clin Pharmacol Ther; 1999 Dec; 66(6):617-24. PubMed ID: 10613618 [TBL] [Abstract][Full Text] [Related]
27. Negative symptoms of schizophrenia are improved by paroxetine added to neuroleptics: a pilot study. Jockers-Scherübl M; Godemann F; Pietzcker A J Clin Psychiatry; 2001 Jul; 62(7):573. PubMed ID: 11488373 [No Abstract] [Full Text] [Related]
28. Platelet serotonin measures in adolescents with conduct disorder. Unis AS; Cook EH; Vincent JG; Gjerde DK; Perry BD; Mason C; Mitchell J Biol Psychiatry; 1997 Oct; 42(7):553-9. PubMed ID: 9376451 [TBL] [Abstract][Full Text] [Related]
29. No correlation between aggression and platelet (3)H-paroxetine binding in obsessive-compulsive disorder patients. Marazziti D; Conti L; Pfanner C; Presta S; Rossi A; Gemignani A; Dell'Osso L; Cassano GB Neuropsychobiology; 2001; 43(3):117-22. PubMed ID: 11287787 [TBL] [Abstract][Full Text] [Related]
30. Long-lasting inhibition of 5-HT uptake of platelets in subjects treated by duloxetine, a potential antidepressant. Kasahara T; Ishigooka J; Nagata E; Murasaki M; Miura S Nihon Shinkei Seishin Yakurigaku Zasshi; 1996 Feb; 16(1):25-31. PubMed ID: 8640460 [TBL] [Abstract][Full Text] [Related]
31. [Use of antidepressant drugs in schizophrenic patients with depression]. Micallef J; Fakra E; Blin O Encephale; 2006; 32(2 Pt 1):263-9. PubMed ID: 16910628 [TBL] [Abstract][Full Text] [Related]
35. Circannual variations in the binding of [3H]lysergic acid diethylamide to serotonin2A receptors and of [3H]paroxetine to serotonin uptake sites in platelets from healthy volunteers. Spigset O; Allard P; Mjörndal T Biol Psychiatry; 1998 May; 43(10):774-80. PubMed ID: 9606533 [TBL] [Abstract][Full Text] [Related]